AIM2 and colorectal carcinoma: On the other hand, we found that AIM2 inhibits BRAF-mutant CRC cell growth mediated by caspase-1 activation to speculate that pyroptosis is involved in this process, and more efforts need to be exerted to verify this finding in future studies.